Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
Research article
[키워드] 2019 New Coronavirus
2019-nCoV2019 New Coronavirus
3-C-like protease
3CLpro3-C-like protease
acting
addition
Antiviral
approved
Comparisons
Coronavirus disease 2019
CoV
COVID
COVID-19
COVID-19coronavirus disease 2019
CoVs
dataset
docking
drug
drugs
EEnvelope
envelope
Epidemics
FDA approved drug
investigated
knowledge
material
membrane protein
MERS
MERS CoVMiddle East Respiratory Syndrome Coronavirus
Middle East respiratory syndrome Coronavirus
Mmembrane protein
MPro
nicotinamide
NNucleocapsid
nucleocapsid
open reading frames
ORFopen reading frames
Phylogenetic
phylogenetics
protease
provided
Research
resolved
ribavirin
Safe
SARS CoV
SARSSevere Acute Respiratory Syndrome CoV
sequence
Severe Acute Respiratory Syndrome CoV
Significance
Spike protein
Sspike protein
systemically
Treatment
Virtual screening
virus
Vitamin
vitamin B12
Wuhan, China
[DOI] 10.1016/j.lfs.2020.117627 [Article Type] Research article
[DOI] 10.1016/j.lfs.2020.117627 [Article Type] Research article